C1 Esterase Inhibitor (C1EI) is a blood product that is licensed in Canada for the treatment of Hereditary Angioedema.
A provincial immunology and allergy working group, chaired by the PBCO, has endorsed the following algorithms. In addition, a sample letter is available, should an Immunologist wish to adapt and implement it for use in their practice.
| Algorithms |
Dated |
| Mar 2013 | |
| Jan 2016 | |
| Jan 2016 | |
| Sample Letter | |
|
Hereditary Angioedema Sample Letter for Patients (from diagnosing physician) |
Revised Dec 2015 |
TMS IVIG Request Process
Other Resources on C1 Esterase Inhibitor:
|
Additional Resources |
|
